Cormorant Asset Management as of March 31, 2023
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 72 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prometheus Biosciences | 11.7 | $178M | 1.7M | 107.32 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 9.7 | $147M | 6.9M | 21.39 | |
Biomea Fusion (BMEA) | 7.3 | $111M | 3.6M | 31.01 | |
Apellis Pharmaceuticals (APLS) | 5.9 | $90M | 1.4M | 65.96 | |
Ambrx Biopharma Sponsored Ads | 5.0 | $76M | 8.5M | 8.92 | |
Bridgebio Pharma (BBIO) | 5.0 | $76M | 4.6M | 16.58 | |
Arcellx Common Stock (ACLX) | 3.2 | $49M | 1.6M | 30.81 | |
89bio (ETNB) | 2.8 | $43M | 2.8M | 15.23 | |
Enliven Therapeutics (ELVN) | 2.8 | $42M | 1.9M | 21.90 | |
Avidity Biosciences Ord (RNA) | 2.6 | $40M | 2.6M | 15.35 | |
Protagonist Therapeutics (PTGX) | 2.6 | $39M | 1.7M | 23.00 | |
Pliant Therapeutics (PLRX) | 2.5 | $38M | 1.4M | 26.60 | |
Erasca (ERAS) | 2.1 | $33M | 11M | 3.01 | |
Aerovate Therapeutics (AVTE) | 2.1 | $32M | 1.6M | 20.17 | |
Design Therapeutics (DSGN) | 2.0 | $30M | 5.2M | 5.77 | |
Rain Therapeutics | 1.7 | $26M | 3.0M | 8.74 | |
Immuneering Corp Class A Com (IMRX) | 1.5 | $23M | 2.4M | 9.71 | |
Monte Rosa Therapeutics (GLUE) | 1.5 | $23M | 2.9M | 7.79 | |
Miragen Therapeutics (VRDN) | 1.4 | $22M | 850k | 25.44 | |
Vectivbio Hldg Ord Shs | 1.4 | $22M | 2.5M | 8.51 | |
Edgewise Therapeutics (EWTX) | 1.3 | $20M | 2.9M | 6.67 | |
Axsome Therapeutics (AXSM) | 1.2 | $19M | 300k | 61.68 | |
Tarsus Pharmaceuticals (TARS) | 1.2 | $18M | 1.4M | 12.57 | |
Axonics Modulation Technolog (AXNX) | 1.2 | $18M | 322k | 54.56 | |
Viking Therapeutics (VKTX) | 1.2 | $18M | 1.1M | 16.65 | |
Tango Therapeutics (TNGX) | 1.1 | $16M | 4.1M | 3.95 | |
Sarepta Therapeutics (SRPT) | 1.0 | $15M | 110k | 137.83 | |
Cabaletta Bio (CABA) | 1.0 | $15M | 1.8M | 8.27 | |
Rocket Pharmaceuticals (RCKT) | 1.0 | $15M | 869k | 17.13 | |
Karuna Therapeutics Ord | 1.0 | $15M | 80k | 181.64 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.9 | $14M | 576k | 23.79 | |
Astria Therapeutics (ATXS) | 0.9 | $13M | 1.0M | 13.30 | |
Morphic Hldg (MORF) | 0.8 | $12M | 325k | 37.64 | |
Rapt Therapeutics (RAPT) | 0.8 | $12M | 650k | 18.35 | |
Cymabay Therapeutics | 0.7 | $11M | 1.3M | 8.72 | |
Olema Pharmaceuticals (OLMA) | 0.7 | $11M | 3.1M | 3.47 | |
Cytokinetics Com New (CYTK) | 0.7 | $10M | 296k | 35.19 | |
Vaxcyte (PCVX) | 0.7 | $10M | 275k | 37.48 | |
Longboard Pharmaceuticals In | 0.6 | $9.4M | 2.4M | 4.01 | |
Stoke Therapeutics (STOK) | 0.6 | $9.1M | 1.1M | 8.33 | |
Prime Medicine (PRME) | 0.6 | $9.0M | 734k | 12.30 | |
Lianbio Sponsored Ads (LIANY) | 0.5 | $8.3M | 4.3M | 1.96 | |
Cogent Biosciences (COGT) | 0.5 | $7.6M | 700k | 10.79 | |
Pharvaris N V (PHVS) | 0.4 | $6.6M | 817k | 8.06 | |
Vigil Neuroscience (VIGL) | 0.4 | $6.0M | 617k | 9.79 | |
Atea Pharmaceuticals (AVIR) | 0.3 | $5.2M | 1.5M | 3.35 | |
Verve Therapeutics (VERV) | 0.3 | $5.0M | 350k | 14.42 | |
Annexon (ANNX) | 0.3 | $4.8M | 1.3M | 3.85 | |
Ideaya Biosciences (IDYA) | 0.3 | $4.8M | 350k | 13.73 | |
Gh Research Ordinary Shares (GHRS) | 0.3 | $4.7M | 593k | 7.99 | |
Greenlight Biosciencs Hlds P Common Stock | 0.3 | $4.0M | 9.2M | 0.43 | |
Icosavax | 0.2 | $3.7M | 644k | 5.80 | |
Elevation Oncology (ELEV) | 0.2 | $3.7M | 2.0M | 1.90 | |
Bioatla (BCAB) | 0.2 | $3.2M | 1.2M | 2.68 | |
Fulcrum Therapeutics (FULC) | 0.2 | $3.1M | 1.1M | 2.85 | |
Poseida Therapeutics I (PSTX) | 0.2 | $3.1M | 1.0M | 3.08 | |
Eledon Pharmaceuticals (ELDN) | 0.2 | $2.9M | 1.2M | 2.36 | |
Alx Oncology Hldgs (ALXO) | 0.2 | $2.8M | 612k | 4.52 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $2.2M | 562k | 3.85 | |
Galecto | 0.1 | $2.0M | 1.0M | 1.99 | |
Talaris Therapeutics | 0.1 | $1.7M | 901k | 1.88 | |
X4 Pharmaceuticals (XFOR) | 0.1 | $1.4M | 1.6M | 0.87 | |
Biohaven (BHVN) | 0.1 | $1.1M | 82k | 13.66 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $1.1M | 273k | 4.01 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $722k | 392k | 1.84 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.0 | $662k | 225k | 2.94 | |
Leap Therapeutics | 0.0 | $504k | 1.5M | 0.34 | |
Graphite Bio | 0.0 | $489k | 200k | 2.45 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $458k | 288k | 1.59 | |
Harpoon Therapeutics | 0.0 | $402k | 541k | 0.74 | |
Atreca Cl A Com (BCEL) | 0.0 | $364k | 319k | 1.14 | |
Orchard Therapeutics Spon Ads New | 0.0 | $138k | 26k | 5.38 |